21 October 2013
The Board of directors of “Rosnano”, OJSC has approved a deal, foreseeing investment of 990K RUB in the charter capital of the established “Managing Company “Rosnano”, LLC. In future it will become private, and the idea of privatization of “Rosnano” recedes into the past. The Managing Company is established in accordance with approved in June, 2012 new strategy of “Rosnano”, the core of which is separation of management functions and assets owning.
In order to implement plants, “Rosnano” will allocate the managing company (which correspond the global practice), which will manage the “Rosnano” itself, and then new funds of nanotechnologies, which will be established. Thus, the “Rosnano” accounts to attract in Russian industry of nanotechnologies additional private investments.
In summer, 2013 the Ministry of the economy development Aleksey Ulyukaev announced about plans of gradual 100% privatization “Rosnano” up to 2016. However a new strategy of “Rosnano” supposes sales to private investors not stocks of the OJSC, but shares in the Managing company – firstly 10% (more 10% can buy out management). Nowadays the offer of “Rosnano” for the Government is to absolutely deny from privatization plans of “Rosnano”: the company is ready to find investors for investments in Russian high-tech companies, creating new funds.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024